Quantitative FLIPLong and FLIPShort mRNA expression in BMMCs and corresponding NF-κB activity in different MDS categories
Patient no. . | MDS classification . | NF-κB level* . | FLIPLong, × 10-3 . | FLIPShort, × 10-3 . | FLIPLong/FLIPShort, × 103 . |
|---|---|---|---|---|---|
| 3 | RA | 0.9 | 0.2 | 0.7 | 0.28 |
| 14 | RAEB | 6.79 | 0.28 | 0.32 | 0.88 |
| 17 | RAEB | 5.86 | 0.44 | 0.61 | 0.72 |
Patient no. . | MDS classification . | NF-κB level* . | FLIPLong, × 10-3 . | FLIPShort, × 10-3 . | FLIPLong/FLIPShort, × 103 . |
|---|---|---|---|---|---|
| 3 | RA | 0.9 | 0.2 | 0.7 | 0.28 |
| 14 | RAEB | 6.79 | 0.28 | 0.32 | 0.88 |
| 17 | RAEB | 5.86 | 0.44 | 0.61 | 0.72 |
Relative levels of FLIPLong and FLIPShort expression in bone marrow mononuclear cells using quantitative real-time PCR.
Values for each gene were normalized to expression levels of β2-microglobulin.
As defined in Table 1